Back

Prolonging and escalating dual antiplatelet therapy duration: how, when and why?

28 August 2023 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more Interventional Cardiology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor David Cohen

Cardiovascular Research Institute, New York City (United States of America)

3 More presentations in this session

Presentation thumbnail
Assessing bleeding and ischaemic risk: which tools and for whom?
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
Shortening dual antiplatelet therapy duration: how, when and why?
Doctor V. Paradies (Rotterdam, NL)
Slides Video
Presentation thumbnail
De-escalating dual antiplatelet therapy after acute coronary syndrome
Associate Professor J. Siller-Matula (Vienna, AT)
Slides Video

Access the full session

Session thumbnail
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: pro
thumbnail
Congress Presentation
Shortening dual antiplatelet therapy duration: how, when and why?
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources